Polaris - Industry-Led Initiative to Critically Assess ML for Real-World Drug Discovery

Explore a conference talk that delves into Polaris, an industry-led initiative aimed at critically assessing machine learning applications in real-world drug discovery. Learn about the challenges and opportunities in integrating ML technologies into pharmaceutical research and development processes. Gain insights from speaker Cas Wognum as they discuss the collaborative efforts between industry partners to evaluate and validate ML models for practical use in drug discovery workflows. Understand the importance of rigorous assessment and benchmarking in ensuring the reliability and effectiveness of ML tools in the pharmaceutical sector. Discover how Polaris aims to bridge the gap between academic research and industrial implementation of ML techniques in drug development.